Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system (Q39592366)

13 September 2017

Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

Kyoko Mori

1

1 reference

13 September 2017

Masanori Ikeda

2

1 reference

13 September 2017

Yasuo Ariumi

3

1 reference

13 September 2017

Hiromichi Dansako

4

1 reference

13 September 2017

Takaji Wakita

5

1 reference

13 September 2017

Nobuyuki Kato

6

1 reference

13 September 2017

12 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

157

1 reference

13 September 2017

1

1 reference

13 September 2017

61-70

1 reference

DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Interferon-based therapy of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Ribavirin improves early responses to peginterferon through improved interferon signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Characterization of ribavirin uptake systems in human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Efficient replication systems for hepatitis C virus using a new human hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Cell entry and export of nucleoside analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Antiviral action of ribavirin in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Structural and Functional Analysis of Hepatitis C Virus Strain JFH1 Polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.02.005

10.1016/J.VIRUSRES.2011.02.005

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference